Related Experiment Videos
Effect of phorbol esters on alloimmune cytolysis
Cancer Research
|December 1, 1982
Summary
Low doses of 12-O-tetradecanoylphorbol-13-acetate (TPA) enhance T-lymphocyte killing of specific target cells. This tumor promoter boosts cytolytic activity without affecting specificity, but higher doses inhibit it.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- 12-O-tetradecanoylphorbol-13-acetate (TPA) is a known tumor promoter.
- Cytolytic T-lymphocytes play a crucial role in cell-mediated immunity.
- The effect of TPA on T-lymphocyte function is not fully understood.
Purpose of the Study:
- To investigate the impact of TPA on the cytolytic activity of alloimmune T-lymphocytes.
- To determine the dose-dependent effects of TPA on T-lymphocyte-mediated killing.
- To elucidate the cellular requirements and specificity of TPA-induced augmentation.
Main Methods:
- Alloimmune C57BL/6 splenocytes were treated with varying concentrations of TPA.
- Cytolytic activity was measured using a 51Cr release microcytotoxicity assay against P815 target cells.
- Experiments involved removal of adherent cells and treatment with anti-Thy 1,2 antibody and complement.
Main Results:
- Low concentrations of TPA (0.3-3.0 ng/ml) significantly enhanced the killing of specific target cells.
- Higher TPA concentrations (30-100 ng/ml) significantly inhibited cytolytic function.
- The augmentation required sensitized T-lymphocytes and was mediated by T-cells, independent of macrophages.
- Specificity of killing was maintained against syngeneic and third-party targets.
Conclusions:
- Low-dose TPA can augment the specific cytolytic activity of alloimmune T-lymphocytes.
- TPA's effect is dose-dependent, with higher concentrations being inhibitory.
- The findings highlight a complex interaction between TPA and T-cell mediated cytotoxicity.